<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>To study insulin-like growth factor 2 (IGF2) imprinting in BWS (<z:e sem="disease" ids="C0004903" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Beckwith-Wiedemann syndrome</z:e>, an <z:hpo ids='HP_0001548'>overgrowth</z:hpo> syndrome associated with Wilms and other <z:e sem="disease" ids="C0027654" disease_type="Neoplastic Process" abbrv="">embryonal tumours</z:e>), we examined allele-specific expression using an Apal polymorphism in the 3' untranslated region of IGF2 </plain></SENT>
<SENT sid="1" pm="."><plain>Four of six BWS fibroblast strains demonstrated biallelic expression, as did the tongue tissue from one of these patients </plain></SENT>
<SENT sid="2" pm="."><plain>Paternal heterodisomy was excluded for <z:hpo ids='HP_0000001'>all</z:hpo> BWS patients with biallelic expression, suggesting strongly that the BWS phenotype in some patients involves disruption of IGF2 imprinting </plain></SENT>
<SENT sid="3" pm="."><plain>Constitutional loss of IGF2 imprinting in a subgroup of our BWS patients, and recent reports of loss of imprinting in <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:e sem="disease" ids="C0027708" disease_type="Neoplastic Process" abbrv="">Wilms tumour</z:e>, further strengthens the view that IGF2 overexpression plays an important role in somatic <z:hpo ids='HP_0001548'>overgrowth</z:hpo> and the development of <z:e sem="disease" ids="C0027654" disease_type="Neoplastic Process" abbrv="">embryonal tumours</z:e> </plain></SENT>
</text></document>